Skip to main content
Clinical Trials/NCT04155632
NCT04155632
Completed
Phase 2

Neurocircuit Strategy to Decrease Cocaine Cue Reactivity

Medical University of South Carolina1 site in 1 country32 target enrollmentDecember 18, 2020

Overview

Phase
Phase 2
Intervention
Theta-burst stimulation (TBS)
Conditions
Cocaine-Related Disorders
Sponsor
Medical University of South Carolina
Enrollment
32
Locations
1
Primary Endpoint
Change in Orbitofrontal Cortex (OFC) BOLD Signal During Cocaine Cue Reactivity Task (Pre- vs. Post-TBS)
Status
Completed
Last Updated
7 months ago

Overview

Brief Summary

The overarching goal of this project is to examine the effect of combining theta burst stimulation (TBS) and N-acetylcysteine (NAC) on cocaine craving and brain response to cocaine-related images.

Registry
clinicaltrials.gov
Start Date
December 18, 2020
End Date
March 9, 2023
Last Updated
7 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 1\. Age 18-65
  • English fluency
  • Meet criteria for cocaine use disorder (CUD), as determined by DSM-V criteria, using the Structured Clinical Interview for DSM-V.
  • 5\. Enrolled in an intensive outpatient treatment program (MUSC Center for Drug and Alcohol Programs Intensive Outpatient Program (CDAP-IOP) or currently engaged in treatment for substance related problems.
  • 6\. Able to read and understand questionnaires and informed consent
  • Lives within 50 miles of the study site.
  • Is not at elevated risk of seizure (i.e., does not have a history of seizures, is not currently prescribed medications known to lower seizure threshold)
  • Does not have metal objects in the head/neck.
  • Does not have a history of traumatic brain injury, including a head injury that resulted in hospitalization, loss of consciousness for more than 10 minutes, or having ever been informed that they have an epidural, subdural, or subarachnoid hemorrhage.
  • 11\. Does not have a history of claustrophobia leading to significant clinical anxiety symptoms.

Exclusion Criteria

  • Past head injury or primary neurological disorder associated with MRI abnormalities, including dementia, MCI, brain tumors, epilepsy, Parkinson's disease, or demyelinating diseases
  • Any physical or intellectual disability affecting completion of assessments
  • Any contraindication to MRI
  • Current or past psychosis
  • ECT in last 6 months
  • Among females, pregnancy at screening will be exclusionary. Females of child bearing potential must agree to undergo a pregnancy test 72 hours prior to the fMRI scanning session and regularly before and during the medication trial. They must further agree to notify the study physician or PA if they become pregnant during the study.
  • Clinical Institute Withdrawal Assessment (CIWA-Ar) scale will be used to assess alcohol withdrawal. Individuals with CIWA \> 8 will be excluded.
  • Individuals with unstable medical illness (e.g., hypertension, diabetes, myocardial infarction)
  • Has current suicidal ideation or homicidal ideation.
  • Has the need for maintenance or acute treatment with any psychoactive medication including anti-seizure medications and medications for ADHD

Arms & Interventions

N-acetylcysteine + Theta Burst Stimulation

Intervention: Theta-burst stimulation (TBS)

N-acetylcysteine + Theta Burst Stimulation

Intervention: N-acetylcysteine

N-acetylcysteine + Sham Theta Burst Stimulation

Intervention: N-acetylcysteine

Placebo + Theta Burst Stimulation

Intervention: Theta-burst stimulation (TBS)

Outcomes

Primary Outcomes

Change in Orbitofrontal Cortex (OFC) BOLD Signal During Cocaine Cue Reactivity Task (Pre- vs. Post-TBS)

Time Frame: From baseline to immediately post-TBS

Measured using fMRI during cocaine cue reactivity task. Percent BOLD signal change in OFC from baseline (Visit 2) to post-TBS (Visit 3). Measured using functional MRI during a cocaine cue reactivity task. The outcome reflects the change in raw BOLD signal in the orbitofrontal cortex (OFC) between baseline and post-TBS sessions. Signal change was calculated by comparing activation during cocaine-related image blocks versus neutral image blocks. Values are reported as raw BOLD signal units (not percentages).

Change in POMS Score From Baseline to Post-TBS"

Time Frame: From baseline to immediately post-TBS

Total POMS score measured before and after TBS. Higher scores indicate worse mood.

Change in Cocaine Craving Rating From Baseline to Post-TBS

Time Frame: From baseline to immediately post-TBS

Self-reported craving measured using NRS (1-10) before and after TBS. Higher scores indicate greater craving.

Study Sites (1)

Loading locations...

Similar Trials